RPS Estonia OÜ
RPS Estonia OÜ is a OÜ based in Tallinn, registry code 12169313, status: active. Main activity: All other professional, scientific and technical activities n.e.c.. According to EMTA, turnover for Q3 2026 was €400 372 with 20 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 400 372 €above 98% of companiesindustry median 9 242 € · companies in the industry: 2 536
- Labour taxes per employee 7 478 €above 98% of companiesindustry median 1 194 € · companies in the industry: 1 746
- Revenue · 2024 1.7 mn €above 98% of companiesindustry median 6 500 € · companies in the industry: 7 799
- Net profit margin · 2024 6.9 %above 44% of companiesindustry median 11.3 % · companies in the industry: 5 599
Taxes and turnover
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 400 372 | 138 210 | 149 568 | 20 |
| Q2 2026 | 382 334 | 130 556 | 141 074 | 19 |
| Q1 2026 | 378 700 | 117 796 | 127 045 | 19 |
| Q4 2025 | 301 487 | 131 296 | 141 485 | 16 |
| Q3 2025 | 465 423 | 177 825 | 191 010 | 17 |
| Q2 2025 | 385 201 | 163 978 | 177 597 | 20 |
| Q1 2025 | 378 574 | 149 583 | 161 129 | 20 |
| Q4 2024 | 439 160 | 162 388 | 174 137 | 20 |
| Q3 2024 | 447 843 | 156 916 | 166 984 | 21 |
| Q2 2024 | 457 577 | 152 148 | 163 110 | 21 |
| Q1 2024 | 410 094 | 141 896 | 151 507 | 21 |
| Q4 2023 | 380 331 | 133 207 | 143 125 | 21 |
| Q3 2023 | 203 981 | 152 391 | 163 827 | 21 |
| Q2 2023 | 798 260 | 124 417 | 134 017 | 21 |
| Q1 2023 | 187 802 | 121 884 | 130 940 | 19 |
| Q4 2022 | 305 689 | 115 508 | 123 873 | 19 |
| Q3 2022 | 313 168 | 101 202 | 108 628 | 18 |
| Q2 2022 | 210 470 | 71 602 | 76 783 | 15 |
| Q1 2022 | 214 152 | 62 349 | 66 823 | 12 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Other professional, scientific and technical activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2024 | 1 710 933 | 118 823 | 1 565 619 | 730 025 | 510 134 | 21 |
| 2023 | 1 510 184 | 101 041 | 1 390 198 | 1 041 750 | 391 311 | 21 |
| 2022 | 1 130 466 | 67 499 | 1 029 004 | 2 257 586 | 290 271 | 16 |
| 2021 | 499 366 | 17 372 | 453 507 | 1 248 860 | 222 772 | 7 |
| 2020 | 502 582 | 23 764 | 451 476 | 888 946 | 205 399 | 9 |
| 2019 | 427 949 | 30 824 | 351 248 | 389 117 | 181 635 | 9 |
| 2018 | — | — | — | — | — | 7 |
| 2017 | — | — | — | — | — | 8 |
| 2016 | — | — | — | — | — | 7 |
| 2015 | — | — | — | — | — | 5 |
| 2014 | — | — | — | — | — | 5 |
| 2013 | — | — | — | — | — | 4 |
| 2012 | — | — | — | — | — | 2 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 12 Dec 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 4 Dec 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 29 Feb 2024 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 16 May 2023 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 21 May 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 6 Aug 2020 | Company’s own | e-Äriregister |
Board
- Barry Edward BalfeBoard member · since 17 Nov 2023
- John SheahanBoard member · since 17 Nov 2023
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- ReSearch Pharmaceutical Services Netherlands B.V.Legal person · 2 500 €
Beneficial owners
- Ciaran MurrayIndirect ownership · IRL · since 5 May 2023
- Eugene Pacelli Mary McCagueIndirect ownership · IRL · since 5 May 2023
- Joan GarahyIndirect ownership · IRL · since 5 May 2023
- John ClimaxIndirect ownership · IRL · since 5 May 2023
- Julie Ann O'NeillIndirect ownership · IRL · since 5 May 2023
- Linda GraisIndirect ownership · USA · since 5 May 2023
- Ronan MurphyIndirect ownership · IRL · since 5 May 2023
- Stephen CutlerIndirect ownership · USA · since 5 May 2023
Founders and other persons
- ReSearch Pharmaceutical Services Netherlands B.V.Founder · 2 500 € · 29 Sep 2011
Activities (EMTAK)
- 74991All other professional, scientific and technical activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10160722 / M5 2 Sep 2024 |
Warning of deletion from the register: annual report not filed | 6 Dec 2024 | Deficiencies eliminated 5 Dec 2024 |
|
| Ä 10160722 / M4 9 Jul 2024 |
Warning of deletion from the register: annual report not filed | 12 Oct 2024 | Deficiencies eliminated 24 Aug 2024 |
|
| Ä 10160722 / 16 17 Nov 2023 |
Amendment entry | In force 17 Nov 2023 |
||
| Ä 10160722 / M3 9 Nov 2023 |
Procedural ruling | 19 Nov 2023 | Deficiencies eliminated 17 Nov 2023 |
|
| Ä 10160722 / M2 6 Oct 2023 |
Warning of deletion from the register: annual report not filed | 9 Jan 2024 | Deficiencies eliminated 1 Mar 2024 |
|
| Ä 10160722 / 15 3 Sep 2023 |
Amendment entry | In force 3 Sep 2023 |
||
| Ä 10160722 / 14 3 May 2023 |
Amendment entry | In force 3 May 2023 |
||
| Ä 10160722 / 13 4 Feb 2019 |
Amendment entry | In force 4 Feb 2019 |
||
| Ä 10160722 / 12 5 Oct 2018 |
Amendment entry | In force 5 Oct 2018 |
||
| Ä 10160722 / 11 2 Aug 2018 |
Amendment entry | In force 2 Aug 2018 |
||
| Ä 10160722 / 10 2 Aug 2018 |
Amendment under Commercial Code § 525 (2) | In force 2 Aug 2018 |
||
| Ä 10160722 / 9 15 Feb 2018 |
Amendment entry | In force 15 Feb 2018 |
||
| Ä 10160722 / M1 9 Feb 2018 |
Procedural ruling | 24 Feb 2018 | Deficiencies eliminated 9 Feb 2018 |
|
| Ä 10160722 / 8 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 10160722 / 7 2 Dec 2017 |
Amendment entry | In force 2 Dec 2017 |
||
| Ä 10160722 / 6 14 Sep 2016 |
Amendment entry | In force 14 Sep 2016 |
||
| Ä 10160722 / 5 17 Oct 2013 |
Amendment entry | In force 17 Oct 2013 |
||
| Ä 10160722 / 4 2 Oct 2013 |
Amendment entry | In force 2 Oct 2013 |
||
| Ä 10160722 / 3 7 Aug 2013 |
Amendment entry | In force 7 Aug 2013 |
||
| Ä 10160722 / 2 26 Mar 2012 |
Amendment entry | In force 26 Mar 2012 |
||
| Ä 10160722 29 Sep 2011 |
First entry | In force 29 Sep 2011 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data